KMT2A/MLL Peptide

Product Discontinued

KMT2A/MLL Peptide Summary

• Description: A peptide to MLL.
• Specificity: This peptide is specific for NB600-248 only.
• Protein/Peptide Type: Peptide
• Gene: KMT2A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NB600-248.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -80C. Avoid freeze-thaw cycles.
• Buffer: Tris-buffered Saline and 0.1% BSA
• Preservative: 0.09% Sodium Azide
• Concentration: 0.2 mg/ml

Alternate Names for KMT2A/MLL Peptide

• ALL1
• ALL-1MLL/GAS7
• CXXC7TET1-MLL
• CXXC-type zinc finger protein 7
• EC 2.1.1.43
• HRXFLJ11783
• HTRX
• HTRX1MLL-AF4 der(11) fusion protein
• KMT2ACDK6/MLL fusion protein
• Lysine N-methyltransferase 2A
• MLL/GAS7 fusion protein
• MLL/GMPS fusion protein
• MLL1
• MLL1A
• myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog)
• myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)
• Trithorax-like protein
• TRX1histone-lysine N-methyltransferase MLL
• Zinc finger protein HRX

Background

A partial tandem duplication within the MLL-gene (MLL-PTD) can be found in 8% of all patients with karyotypically normal acute myeloid leukemia (AML). MLL possibly acts as a transcriptional regulatory factor.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: KMT2A